Filing Details

Accession Number:
0001610717-25-000083
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-20 16:32:22
Reporting Period:
2025-03-18
Filing Date:
2025-03-20
Accepted Time:
2025-03-20 16:32:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501989 Cytomx Therapeutics Inc. CTMX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236395 A Lloyd Rowland C/O Cytomx Therapeutics, Inc.
151 Oyster Point Blvd., Ste. 400
South San Francisco CA 94080
General Counsel No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-03-18 10,203 $0.60 120,594 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").
  2. Includes 30,624 RSUs.